Fludarabine phosphate--looking forward.
Division of Cancer Treatment, National Cancer Institute, Bethesda, MD.
B D
BD
Cheson
D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use*; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy*; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy*; D008232:Lymphoproliferative Disorders / Q000188:drug therapy; D001084:Vidarabine Phosphate / Q000031:analogs & derivatives* / Q000627:therapeutic use
D000964:Antimetabolites, Antineoplastic; D001084:Vidarabine Phosphate; C042382:fludarabine phosphate